Press Releases

GAAP and non-GAAP revenues of $296 million GAAP net income per diluted share of $0.61 Non-GAAP net income per diluted share of $1.08 Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of...

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the third quarter of 2021 before the open of the market on Tuesday,...

Expands nationwide footprint of retail pharmacy customers, adding industry-leading financial management, analytics, and population health solutions to EnlivenHealth division offering Addition of SaaS solutions accelerates EnlivenHealth’s innovation...

Access to expanded engineering resources will accelerate innovation for the Company’s cloud-based solutions portfolio Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and...

New capabilities focus on superior customer experience and innovation to drive maximum value sooner; deliver improved workflow efficiency, expanded automation, and enhanced medication management intelligence Omnicell, Inc. (Nasdaq:OMCL), a leading...

End-to-End Medication Management Platform Fulfills Journey to Fully Autonomous Pharmacy Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that...

Record revenues of $273 million GAAP net income per diluted share of $0.43 Record non-GAAP net income per diluted share of $0.97 Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare...

Strategic acquisition of leading pharmacy SaaS solutions provider supports the Autonomous Pharmacy vision and expands Omnicell’s Advanced Services portfolio Accelerates innovation roadmap for EnlivenHealth division with addition of SaaS solutions...

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has increased its number of board seats from 9 to 10, and has appointed Edward P. Bousa to...

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the second quarter of 2021 before the open of the market on...

Chartwell Pennsylvania, LP , the nation’s leading health-system based provider of home infusion, specialty pharmacy, and enteral nutrition, has partnered with Omnicell to install their IVX Workflow sterile compounding technology to manage...

Represents Omnicell’s 148th Long-Term Partnership with a Top 300 US Health System Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Scripps...

Record revenues of $252 million, an increase of 10% from the prior year period GAAP net income per diluted share of $0.30, Non-GAAP net income per diluted share of $0.83 Added new long-term, sole-source partnership agreements with Top 300 U.S....

Omnicell Division Will Leverage Twilio's Cloud Communications Platform to Power New Personalized Communications Capabilities Omnicell, Inc., (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems...

Adoption of Technology-Enabled Services and Dispensing Solutions Supports Autonomous Pharmacy Vision Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today...

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter of 2021 after the close of the market on...